臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"su k y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 191-215 / 249 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-03-09T06:08:08Z	Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice	Wu S.-L.;Wei T.-Y.;Shu-Wen Lin;Su K.-Y.;Kuo C.-H.; Wu S.-L.; Wei T.-Y.; SHU-WEN LIN; Su K.-Y.; Kuo C.-H.
臺大學術典藏	2020-03-07T06:56:37Z	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Yuan S. ;Yu S.-L. ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Yih-Leong Chang ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.
臺大學術典藏	2020-03-07T06:56:34Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-03-07T06:56:28Z	Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer	Chen C.-C.;Chen H.-Y.;Su K.-Y.;Hong Q.-S.;Yan B.-S.;Chen C.-H.;Pan S.-H.;Yih-Leong Chang;Wang C.-J.;Hung P.-F.;Yuan S.;Chang G.-C.;Chen J.J.W.;Yang P.-C.;Yang Y.-C.;Yu S.-L.; Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; Yan B.-S.; Chen C.-H.; Pan S.-H.; YIH-LEONG CHANG; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L.
臺大學術典藏	2020-03-07T06:56:12Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Yih-Leong Chang;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.
臺大學術典藏	2020-03-07T06:56:12Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2020-03-07T06:56:09Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-03-06T08:25:30Z	Decreased expressions of hepsin in human hepatocellular carcinomas	Tsai Y.-C.; Cheng K.-C.; YUNG-MING JENG; Sheu J.-C.; Lin S.-W.; Su Y.-H.; Tao M.-H.; Su K.-Y.; Chen C.-H.; Chen C.-H.;Su K.-Y.;Tao M.-H.;Lin S.-W.;Su Y.-H.;Tsai Y.-C.;Cheng K.-C.;Yung-Ming Jeng;Sheu J.-C.
臺大學術典藏	2020-03-06T05:26:24Z	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.
臺大學術典藏	2020-03-06T05:26:21Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-03-06T05:26:17Z	Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer	Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; Yan B.-S.; Chen C.-H.; Pan S.-H.; YIH-LEONG CHANG; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L.
臺大學術典藏	2020-03-06T05:26:04Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2020-03-06T05:26:03Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2020-03-06T05:26:00Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-03-05T08:04:01Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; MIN-SHU HSIEH; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Min-Shu Hsieh;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.
臺大學術典藏	2020-03-05T08:03:59Z	Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer	Lin M.-W.;Su K.-Y.;Su T.-J.;Chang C.-C.;Lin J.-W.;Lee Y.-H.;Yu S.-L.;Chen J.-S.;Min-Shu Hsieh; Lin M.-W.; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; MIN-SHU HSIEH
臺大學術典藏	2020-02-11T07:58:43Z	Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice	Hsu Y.-C.; Huang H.-P.; Yu I.-S.; Su K.-Y.; Lin S.-R.; Lin W.-C.; Wu H.-L.; Shi G.-Y.; Tao M.-H.; Kao C.-H.; YAO-MING WU; Martin P.E.; Lin S.-Y.; Yang P.-C.; Lin S.-W.
臺大學術典藏	2020-01-21T01:20:43Z	Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E	Ho B.-C. ;Yu S.-L. ;Chen J.J.W. ;Chang S.-Y. ;Bo-Shiun Yan ;Hong Q.-S. ;Singh S. ;Kao C.-L. ;Chen H.-Y. ;Su K.-Y. ;Li K.-C. ;Cheng C.-L. ;Cheng H.-W. ;Lee J.-Y. ;Lee C.-N. ;Yang P.-C.; Ho B.-C.; Yu S.-L.; Chen J.J.W.; Chang S.-Y.; BO-SHIUN YAN; Hong Q.-S.; Singh S.; Kao C.-L.; Chen H.-Y.; Su K.-Y.; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C.
臺大學術典藏	2020-01-21T01:20:42Z	Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer	Chen C.-C.; Chen H.-Y.; Su K.-Y.; Hong Q.-S.; BO-SHIUN YAN; Chen C.-H.; Pan S.-H.; Chang Y.-L.; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; Yang P.-C.; Yang Y.-C.; Yu S.-L.
臺大學術典藏	2020-01-21T01:20:41Z	Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS	Su K.-Y.;Bo-Shiun Yan;Chiu H.-C.;Yu C.-J.;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Yu S.-L.; Su K.-Y.; BO-SHIUN YAN; Chiu H.-C.; Yu C.-J.; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; Yu S.-L.
臺大學術典藏	2020	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yu C.-J.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; TZU-HSIU TSAI; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.
臺大學術典藏	2020	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Su K.-Y.; Chang Y.-L.; Liu Y.-N.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yu C.-J.; Yang J.C.-H.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.
臺大學術典藏	2020	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU

顯示項目 191-215 / 249 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2851814
	造訪人次 : 44886779 線上人數 : 1268 教育部委託研究計畫計畫執行:國立臺灣大學圖書館